COMPARISON OF PATIENTS WITH RHEUMATOID ARTHRITIS (RA) ON DISEASE REMISSION IN THE EUROPEAN UNION (EU) AND UNITED STATES (US)

被引：0
|
作者：
Narayanan, S. [1 ]
Lu, Y. [2 ]
Hutchings, R. [2 ]
Baskett, A. [2 ]
机构：
[1] Ipsos Healthcare, Columbia, MD USA
[2] Ipsos Healthcare, London, England
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS82
引用
收藏
页码：A167 / A167
页数：1
相关论文
共 50 条
  • [41] Chemokines and matrix metalloproteinase expression in rheumatoid arthritis (RA) patients achieving remission.
    Katrib, A
    Smith, M
    Ahern, M
    Roberts-Thompson, P
    Bertouch, JV
    McNeil, HP
    Youssef, PP
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S78 - S78
  • [42] Should patients with rheumatoid arthritis (RA) measure their disease activity?
    Houssien, DA
    Stucki, G
    Scott, DL
    [J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1529 - 1529
  • [43] Geographic Variation in Disease Burden and Mismatch in Care of Patients With Rheumatoid Arthritis in the United States
    Dowell, Sharon
    Yun, Huifeng
    Curtis, Jeffrey R.
    Chen, Lang
    Xie, Fenglong
    Pedra-Nobre, Manuela
    Wollaston, Dianne
    Najmey, Sawsan
    Elliott, Cynthia Lawrence
    Ford, Theresa Lawrence
    North, Heather
    Dore, Robin
    Dolatabadi, Soha
    Ramanujam, Thaila
    Kennedy, Stacy
    Ott, Stephanie
    Jileaeva, Ilona
    Richardson, Amina
    Kaine, Jeffrey
    Wright, Grace
    Kerr, Gail S.
    [J]. ACR OPEN RHEUMATOLOGY, 2023, 5 (04) : 181 - 189
  • [44] Application of the New American College of Rheumatology/European League Against Rheumatism Rheumatoid Arthritis Remission Criteria in a United States Cohort
    Navarro-Millan, Iris
    Chen, Lang
    Greenberg, Jeffrey D.
    Curtis, Jeffery R.
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S125 - S126
  • [45] SOCIETAL COST OF RHEUMATOID ARTHRITIS (RA) IN THE UNITED STATES: METHODOLOGY FOR INCORPORATING INTANGIBLE COSTS
    Birnbaum, H.
    Pike, C.
    Kaufman, R.
    Marynchenko, M.
    Kidolezi, Y.
    Cifaldi, M.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A16 - A17
  • [46] COST-EFFECTIVENESS OF MONOCLONAL ANTIBODIES (MABS) FOR RHEUMATOID ARTHRITIS (RA) IN THE UNITED STATES
    Jordan, N.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S95 - S95
  • [47] TNF Inhibitor Treatment in Rheumatoid Arthritis (RA) Patients with Moderate Versus High Disease Activity At Baseline: A Comparison of Utility Gains, Response and Remission Rates
    Lie, Elisabeth
    Lillegraven, Siri
    Fagerli, Karen M.
    Uhlig, Till
    Kvien, Tore K.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S220 - S220
  • [48] COMPARISON OF HISTOLOGICAL AND MOLECULAR FEATURES IN PATIENTS WITH AN ACTIVE RHEUMATOID ARTHRITIS AND PATIENTS IN REMISSION
    Ohl, S.
    Frommer, K.
    Rickert, M.
    Rehart, S.
    Mueller-Ladner, U.
    Neumann, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1211 - 1212
  • [49] Psychiatric adverse events reported after COVID-19 vaccination in the European Union (EU), the United States (US) and the United Kingdom (UK)
    Macias Saint-Gerons, D.
    Correa Ghisays, P.
    Tabares-Seisdedos, R.
    [J]. EUROPEAN PSYCHIATRY, 2022, 65 : S74 - S74
  • [50] RA Medication Preferences Among US Patients in an Online Rheumatoid Arthritis Community
    Zhu, Baojin
    Chang, Lawrence
    Qian, Leilei
    Larmore, Cynthia J.
    Tanaka, Yoko
    Araujo, Andre B.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345